Total Current Assets - GlaxoSmithKline PLC (NYSE:GSK) - Alpha Spread
G

GlaxoSmithKline PLC
NYSE:GSK

Watchlist Manager
GlaxoSmithKline PLC
NYSE:GSK
Watchlist
Price: 38.82 USD 1.17% Market Closed
Market Cap: 79.2B USD
Have any thoughts about
GlaxoSmithKline PLC?
Write Note

GlaxoSmithKline PLC
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

GlaxoSmithKline PLC
Total Current Assets Peer Comparison

Comparables:
A
AZN
INDV
HIK
AGY
DPH

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
G
GlaxoSmithKline PLC
NYSE:GSK
Total Current Assets
ÂŁ16.8B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
2%
A
AstraZeneca PLC
NASDAQ:AZN
Total Current Assets
$25.4B
CAGR 3-Years
-2%
CAGR 5-Years
11%
CAGR 10-Years
5%
Indivior PLC
LSE:INDV
Total Current Assets
$864m
CAGR 3-Years
-13%
CAGR 5-Years
-7%
CAGR 10-Years
14%
Hikma Pharmaceuticals PLC
LSE:HIK
Total Current Assets
$2.3B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
8%
Allergy Therapeutics PLC
LSE:AGY
Total Current Assets
ÂŁ35.3m
CAGR 3-Years
-20%
CAGR 5-Years
-7%
CAGR 10-Years
6%
Dechra Pharmaceuticals PLC
LSE:DPH
Total Current Assets
ÂŁ467.9m
CAGR 3-Years
1%
CAGR 5-Years
14%
CAGR 10-Years
10%

See Also

What is GlaxoSmithKline PLC's Total Current Assets?
Total Current Assets
16.8B GBP

Based on the financial report for Jun 30, 2024, GlaxoSmithKline PLC's Total Current Assets amounts to 16.8B GBP.

What is GlaxoSmithKline PLC's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
2%

Over the last year, the Total Current Assets growth was -13%. The average annual Total Current Assets growth rates for GlaxoSmithKline PLC have been -2% over the past three years , -2% over the past five years , and 2% over the past ten years .

Back to Top